Healthcare Blogs and Articles
Healthcare Blogs and Articles
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Jay Bregman, CEO of Andel, says the FDA’s pending crackdown on non‑FDA‑approved GLP‑1 compounds is long overdue and will target the burgeoning market of compounded semaglutide. He estimates roughly 1.5 million patients currently rely on these unapproved products, a figure he believes is conservative. The enforcement could force patients toward employer‑supported or direct‑to‑employer distribution models rather than direct‑to‑consumer platforms. Ultimately, the move may restore incentives for pharma to develop fully approved, breakthrough obesity and diabetes therapies.
BioNTech has filed a Delaware patent‑infringement lawsuit against Moderna, accusing the latter’s next‑generation COVID vaccine mNEXSPIKE of using BioNTech’s streamlined mRNA design. The disputed shot is projected to generate about 55 % of Moderna’s COVID revenue this season, making the case...
Researchers have demonstrated dissolving microneedle (DMN) arrays fabricated using resin‑based 3D‑printed master molds, enabling drug delivery through the inner cheek. The workflow pairs rapid SLA/DLP printing with polymer micromolding, allowing design changes from CAD to mold within hours. Mechanical, dissolution...
Scotland’s cancer diagnosis pathway is lagging, with only 69.9% of urgent referrals meeting the 62‑day treatment target, well short of the 95% benchmark. The National Framework for Effective Cancer Management (2025) outlines ten steps to streamline care, but implementation remains...
Healthcare organizations focus on high‑tech defenses, yet physical and procedural gaps remain a major source of breaches. Low‑tech incidents such as tailgating, unattended devices, and badge sharing contributed to over 51 million compromised records in 2022. The article outlines practical controls—including...
The FDA, backed by HHS, issued a stark warning to compounding pharmacies that market GLP‑1 products such as semaglutide, after Hims & Hers promoted a compounded Wegovy copy. A press release announced intent to restrict non‑approved GLP‑1 APIs and referred...
Researchers at Tokyo Metropolitan University have engineered a charge‑free polymer‑DNA complex using a thymine‑modified poly(ethylene glycol) (PEG) that binds plasmid DNA via annealing. In mouse models the formulation boosted cellular DNA uptake and gene expression up to 14‑fold compared with...
Medical schools increasingly mandate reflective assignments, yet unchecked introspection can devolve into rumination that erodes confidence. The article cites a student’s journal turning from insightful notes to self‑doubt, illustrating how constant, unstructured reflection amplifies perfectionism and anxiety. Drivers include a...
NVIDIA has introduced the SimReady Medical Assets library, a collection of high‑fidelity virtual models designed to train surgical robots across a range of procedures. The assets simulate realistic tissue behavior, instrument interaction, and operating‑room environments, allowing AI algorithms to practice...
The article argues that stringent opioid prescribing guidelines, aggressive DEA oversight, and state medical board prosecutions have created a hidden cost to the U.S. health‑care system. These regulatory and prosecutorial practices restrict legitimate pain management, drive physicians toward defensive medicine,...
A functional‑medicine physician documented a leukemia patient’s four‑week integrative nutrition program that complemented maintenance chemotherapy. The regimen emphasized time‑restricted eating, phytonutrient‑dense low‑carb foods, magnesium repletion, and personalized movement. Laboratory markers showed platelets rise 63%, hemoglobin up 7%, and red cells...
Boston Scientific announced a $14.5 billion acquisition of Penumbra, re‑entering the neurovascular market and expanding its cardiovascular device portfolio. The deal, paid at a 19 % premium with a 73 % cash and 27 % stock mix, targets Penumbra’s thrombectomy and embolization technologies. Boston...
Recent randomized trials testing GLP‑1 receptor agonists such as semaglutide and liraglutide in Alzheimer’s disease patients found no measurable slowing of cognitive decline. Earlier post‑hoc and observational analyses had suggested roughly a 50 % reduction in dementia incidence, raising hopes of...
Eli Lilly announced a $3.5 billion investment to build a new injectable‑medicine plant in Lehigh Valley, Pennsylvania. The facility, slated to break ground in 2026 and run by 2031, will focus on next‑generation obesity and metabolic drugs such as the triple‑agonist retatrutide....
Novartis began construction of a new biomedical research hub in San Diego. The 466,000‑sq‑ft center, part of a $23 billion US R&D and manufacturing program, will house about 1,000 researchers and target neuroscience, oncology, global health, and age‑related diseases. Scheduled to...
WestFax launched Comprehend, an AI‑powered Intelligent Document Processing platform for healthcare, now available across all its service tiers. The solution uses OCR, AI and FHIR‑aligned models to convert inbound fax, email and file‑based documents into searchable PDFs, classify types, and...
The U.S. Food and Drug Administration has granted approval to Adquey, a 1% difamilast topical ointment, for the treatment of mild-to-moderate atopic dermatitis in patients two years and older. Developed by Otsuka and licensed to Acrotech Biopharma, the product is...
ALIS released its Q4 2025 ALIS 500 Clinical Report, the first senior‑living clinical benchmarking study covering 500 communities and 28,800 residents. The report delivers detailed data on resident age, prevalent chronic conditions, comorbidity patterns, and fall incidents, and is paired with an...
Since 2005, 195 rural hospitals have shut down, with 50 closures occurring between 2017 and 2023, deepening access gaps for millions of Americans. Rural residents experience higher rates of diabetes, mental distress, and premature mortality, compounded by looming federal Medicaid...
Cytomegalovirus (CMV) infection, prevalent in most adults, increasingly appears linked to neurodegenerative processes. Large cohort studies show higher CMV IgG levels correlate with accelerated cognitive decline, and post‑mortem analyses detect CMV DNA in a majority of vascular dementia brains. Animal...
Dr. Sriman Swarup warns that the hourly rate in locum tenens contracts is often the least critical factor. He emphasizes that contract clarity—especially around responsibility for cancellations, payment guarantees, and termination triggers—determines whether an assignment is viable. Ambiguous language typically...
The episode dives into Epic's recent rollout of twelve new FHIR APIs tailored for radiation oncology, highlighting how these modern interfaces support the CodeX Exchange of Radiotherapy Summaries Implementation Guide. It explains the distinct nature of radiation oncology—focused on precise...
A new multi‑agent system called DeepRare, built on the DeepSeek‑V3 large language model and over 40 specialized tools, outperformed 15 competing AI models and human physicians in diagnosing rare diseases. Across 6,401 cases covering 2,919 rare conditions, it achieved a...
Hormone therapy has re‑emerged in menopause care, but many clinicians prescribe it as a first‑line fix without evaluating underlying stress, metabolic, or nervous‑system dysfunction. The article argues that estrogen, progesterone, and testosterone are often used to treat fatigue, burnout, and...
The episode examines the deepening crisis in U.S. health care, highlighting recent data that shows health insurance costs now outrank basic necessities for two‑thirds of Americans and that 1.2 million households lost coverage after premium subsidies were cut. Host Trudy Lieberman discusses...
Paul Krugman highlights a growing financial link between the multi‑billion‑dollar wellness industry and right‑wing extremist movements. He notes that U.S. spending on wellness reaches roughly $500 billion annually, with nutritional supplements alone accounting for about $70 billion, while regulators like the FDA...
In a February 20, 2026 Pharm Exec Podcast, ZS CEO Pratap Khedkar, PhD, outlined three converging trends reshaping pharma: heightened AI integration, evolving ecosystem partnerships, and sweeping US‑driven policy reforms. Drawing on his nine‑year tenure leading ZS’s global pharmaceuticals practice and its advanced data‑science...
Midlife women often follow the classic "eat less, move more" mantra yet see stagnant scales because perimenopause and menopause trigger profound physiological shifts. Hormonal fluctuations raise insulin and cortisol, blunt glucose flexibility, and promote fat oxidation over muscle use. Simultaneously,...
Researchers report that the FDA‑approved antiepileptic levetiracetam reduces amyloid‑β42 production in mouse models of Alzheimer’s disease. The drug redirects amyloid precursor protein processing toward the non‑amyloidogenic pathway by modifying synaptic vesicle cycling and increasing surface APP expression. Mass‑spectrometry and electrophysiology...
The episode examines the legal vacuum surrounding AI‑assisted clinical decision‑making, highlighting that while the FDA has cleared over 1,300 AI medical devices, adoption remains low and physicians bear virtually all malpractice liability. Data shows a rapid rise in AI use...
Johnson & Johnson announced a $1 billion investment to build a next‑generation cell‑therapy manufacturing facility in Montgomery County, Pennsylvania, slated to support 500 skilled jobs. The hub is a key element of J&J’s $55 billion U.S. manufacturing, R&D, and technology strategy. Meanwhile,...
A £4.2 million Northern Ophthalmic Research and Innovation Institute (NORI) is being established in North East England to turn routine eye scans into early‑warning tools for serious illnesses. The hub, hosted by the University of Sunderland, will link eye images with...
The NHS is rapidly adopting AI and patient‑facing tools, yet back‑office staff such as roster managers remain stuck with outdated systems. This digital divide fuels stress, mismatched rotas, and higher temporary‑staff costs, contributing to the wider retention crisis. Trusts that...
Rare Disease Week convenes on Capitol Hill, bringing patients, advocates, regulators, and industry together to shape policy for rare disease therapies. Hyman, Phelps & McNamara will be prominently represented, highlighted by Frank Sasinowski receiving the EveryLife Foundation’s Abbey Lifetime Achievement...
The FDA announced it will drop the historic requirement for two adequate and well‑controlled studies in certain new‑drug approval pathways, a move that could accelerate timelines and lower development costs. The change is especially relevant for therapies targeting unmet medical...
The Advisory Committee on Immunization Practices (ACIP) cancelled its scheduled February 25‑27, 2026 meeting, and no new date has been announced. The cancellation occurs amid a wave of senior HHS leadership changes, including the departure of Deputy Secretary Jim O’Neill and General...
The article outlines the four canonical health‑care system models—Beveridge, Bismarck, national single‑payer, and hybrid—and shows that the United States operates a hybrid structure combining elements of each. It highlights WHO’s six criteria for high‑performing systems and notes that despite world‑class...
Eli Lilly reported that its biologic Omvoh (mirikizumab) sustained steroid‑free remission for three years in Crohn’s disease patients in the Phase 3 VIVID‑2 open‑label extension study. More than 90% of participants remained in remission, with 80% experiencing relief from bowel urgency. The...
A recent open‑access study of 514 Canadian seniors examined peripheral inflammation using IL‑6 and C‑reactive protein. The analysis revealed that elevated IL‑6 levels were present in 12% of cognitively normal participants but rose sharply to 36‑55% among Alzheimer’s, mixed dementia,...
The author recounts a recent struggle with Medicare Part D after a prescription fell off the plan’s formulary, raising the out‑of‑pocket cost from the expected $500 to nearly $600. By appealing the denial, the drug was reinstated on the formulary, the...
CoverMyMeds outlines how access and affordability challenges evolve across a biopharma brand’s lifecycle, from launch through loss of exclusivity, and offers actionable, data‑driven strategies to mitigate them. The firm emphasizes real‑time analytics, provider‑focused tools, and tailored patient assistance to reduce...
Researchers used Mendelian randomization to demonstrate that the inflammatory cytokine IL6 directly increases all‑cause mortality, while its soluble receptor IL6R has the opposite effect. Elevated circulating IL6R was linked to lower risk of lung cancer, diabetes, stroke and coronary artery...
Vanda Pharmaceuticals received FDA approval for tradipitant (Nereus®), an oral selective NK1 receptor antagonist, to treat motion‑induced nausea and vomiting. The approval marks the first new drug for motion sickness in more than four decades, highlighting a significant regulatory milestone....
The episode examines Cigna’s settlement with the FTC over its Express Scripts PBM, which was accused of inflating insulin prices through opaque rebate deals. Key provisions require Cigna to prioritize lower‑cost drug versions, base patient copays on net prices, increase...
A study of 93 adults in remission from major depressive disorder used research‑grade wrist actigraphy to monitor sleep and activity for up to two years. The analysis of nearly 32,000 days of data showed that increasingly irregular sleep patterns and...
The FNIH Biomarkers Consortium unveiled a “clock model” that uses a single blood test to forecast Alzheimer’s disease symptom onset 3‑4 years before clinical presentation. The model aggregates plasma biomarkers into a temporal trajectory, and a new web‑based visualization tool...
SEQSTER PDM, Inc. unveiled its 1-Click Data Refinery™ – an enterprise‑grade engine that converts raw, patient‑consented EHR data into clean, structured, AI‑ready records. The platform normalizes, deduplicates and harmonizes data across health systems, delivering longitudinal patient views suitable for rapid...
The episode explains that traditional user‑centric identity systems are insufficient for autonomous AI agents in healthcare, which need a dedicated agentic identity layer to manage fine‑grained PHI access, audit trails, and delegation across humans and machines. It highlights the regulatory...
The Centers for Medicare & Medicaid Services announced a third round of drug price negotiations that for the first time includes Part B physician‑administered therapies. By extending the Inflation Reduction Act’s pricing provisions to infused medicines, the move pulls doctors into...
Median Technologies has named veteran imaging executive Oran Muduroglu as President of its U.S. subsidiary, Median eyonis Inc., to spearhead the commercial launch of eyonis LCS, an AI‑powered lung‑cancer‑screening SaMD that recently received FDA 510(k) clearance. The rollout will leverage a defined Medicare reimbursement...
